The University of Maryland Center for Vaccine Development

Funding

The following is a non-exhaustive list of current and recent grants and contracts awarded to CVD faculty, in the following broad categories: Federal contracts, Federal grants, Federal training grants and non-Federal grants and contracts. Further information on our NIH awards can be obtained from the NIH Computer Retrieval of Information on Scientific Projects system.

Federal Contracts

W.A. Blattner, PI
CDC     200-2003-01716
9/03 – 9/07
Collection of Serum Specimens Suitable for Validation of Assays with HIV-1

M.M. Levine, PI
NIH     N01-AI-25461
6/02 – 12/08
Evaluation of Control Measures Against Infectious Diseases Other Than AIDS

C.V. Plowe, PI
US Army Medical Research and Development Command
3/06 – 3/08
Pediatric Clinical Trial of the WRAIR - GSK Malaria Vaccine

M.B. Sztein, PI
NIH     N01-AI-30028
7/03 – 7/10
Food and Waterborne Disease Intergrated Research Network - Immunology Research Unit (IRU)

Dr. Carol Tacket

C.O. Tacket, PI
NIH     N01-AI-40014
2/04 – 2/11
Food and Waterbourne Disease Integrated Research Network - Clinical Research Unit (CRU)

Federal Grants

E.M. Barry, PI
NIH/NIAID   R01-AI055943
6/04 – 5/08
Conserved Pneumococcal Protein Live-Vector Vaccine

E.M. Barry, PI
NIH/NIAID   R01-AI059223
6/06 – 5/10
Shigella Dysenteriae Vaccine Construction

W.A. Blattner, PI
Fogarty International Center    R03-TW006876
4/04 – 3/08
Ego Network-Based HIV Risk Assessment for Vaccine Trials

W.A. Blattner, PI
CDC     U62-CCU-322421-02
9/02 – 3/08
IHV/UMD Technical Assistance for Global Aids Program in Nigeria

W.A. Blattner, PI
NIH     U01-AI069447
2/07 – 11/08
IHV Clinical Trials Network

W. Chen, Career Awardee
NIH    K12-RR023250 (A. Shuldiner, PI)
3/07 – 3/12
Early Dendritic Cell Function in Response to Influenza Antigens

A.S. Cross, PI
NIH     R01-AI042181
5/03 – 4/08
Evaluation of Anti-endoxin Vaccine for Human Use

A.S. Cross, PI
NIH     R21-AI059093
3/05 – 2/08
Early Events During Infection with Anthrax

J.B. Kaper, PI
NIH     R37-AI021657
4/04 – 3/09
Molecular Genetics of Enteropathogenic E.coli Adhesion

J.B. Kaper, PI
NIH     R01-AI019716
2/01 – 6/11
Development of a Live Oral Cholera Vaccine

J.B. Kaper, PI
NIH     R01-DK58957
9/00 – 6/10
Novel E. coli 0157:H7 Intestinal Colonization Factors

K.L. Kotloff, Co-Investigator
NIH     U01-AI-60591 (University of Tennessee; J. Dale, PI)
9/04 – 8/09
Vaccination Prevention of Rheumatic Fever

M.K. Laufer, PI
NIH     K23-AI059316
7/04 – 3/09
Molecular EPI of Drug-Resistant Malaria

M.M. Levine, PI
NIH     R01-AI029471
4/98 – 2/09
Recombinant and Live Oral Salmonella Typhi Hybrid Vaccines

M.M. Levine, PI
NIH     U54-AI057168
9/03 – 2/08
Defense Against Biowarfare and Emerging Infection Agents

J.P. Nataro, PI
NIH     R01-AI033096
7/00 – 2/10
Virulence of Enteroaggregative E. coli

J.P. Nataro, PI
NIH     R01-AI056578
9/03 – 1/08
Vaccines Against Agents of Bioterror

M.F. Pasetti, PI
NIH    R01-AI065760
2/06 – 1/11
Immune Responses to Biodefense Vaccines in Early Life

C.V. Plowe, PI
NIH    U01-AI044824
9/99 – 5/08
Clinical Trial of Chloroquine Combinations of Malawi

C.V. Plowe, PI
NIH     U01-AI047858
9/01 – 5/08
TS Prophylaxis and Drug-Resistant Malaria in Malawi

Dr. Marcelo Sztein

C.V. Plowe, PI
NIH     U19-AI0065683
9/05 – 4/10
Malaria Vaccine Trials in Mali

J. Simon, PI 
NIH     N01-AI045250 (St. Louis University)
11/02 – 8/11
HSV Vaccine Trial for Women

J. Simon, PI 
NIH     K23-AI065759
8/05 – 6/10
Immunological Correlates of Protection in Shigellosis

M.B. Sztein, PI
NIH     R01-AI036525
9/94 – 11/11
Immune mechanisms of protection in S. Typhi vaccines

M.B. Sztein, PI
NIH     R01-AI057927
5/04 – 4/09
Protective Immunity by Shigella Vaccines in Humans

Federal Training Grants

W.A. Blattner, PI
NIH/Fogarty International Center     D43-TW001041
9/98 – 5/09
IHV UMB AITRP in Brazil, the Caribbean and Nigeria

M.M. Levine, PI
NIH Training Grant     T32-AI007524
7/97 – 6/07
Fellowship Training Program in Vaccinology

C.V. Plowe, PI
NIH Training Grant     D43-TW001589
9/00 – 3/11
Malaria Research Training in Mali

Non-Federal Grants and Contracts

W.A. Blattner, PI
Doris Duke Foundation
1/06 – 12/07
Peer Educators Impact on HIV Medication Adherence

W.A. Blattner, PI
CDC U2G PS000651
5/04 – 9/09
PEPFAR Nigeria ARV Therapy and Care

W.A. Blattner, Co-Investigator
Catholic Relief Charities (IHV Subcontract)
3/04 – 2/09
Rapid Expansion for HIV+ Persons in Africa

J. D. Campbell, PI
Sanofi Pasteur
12/05 – 3/08
Bacterial Antibodies in Children Receiving Menactra

K.L. Kotloff, PI
Merck Vaccine Network
7/03 – 6/07
Mali Immunization Training Initiative

M.M. Levine, PI
Bill and Melinda Gates Foundation Grant # 1187
8/00 – 12/07
Mucosal Measles Vaccine for Immunizing Young Infants

M.M. Levine, PI
Bill and Melinda Gates Foundation Grant # 32470
11/04 – 11/08
Haemophilus Influenza type b (Hib) Conjugate Vacines in Infants in Mali, West Africa

M.M. Levine, PI
Bill and Melinda Gates Foundation Grant # 38874
5/06 – 3/11
Diarrheal Disease in Infants and Young Children in Developing Countries

C.V. Plowe, PI
Doris Duke Distinguished Clinical Scientist Award
1/07 – 12/11
Genetic Diversity and Malaria Vaccine Efficacy

C.O. Tacket, PI
Ligocycte Pharmaceuticals, Inc.
3/07 – 1/08
Vaccines and Therapeutics to Counter Biological Threats (Norwalk VLP Vaccine)

M.D. Tapia, PI
Program for Appropriate Technology in Health (PATH)
Bill and Melinda Gates Foundation
4/06 – 1/09
Meningitis Vaccine Project

M.D. Tapia, PI
PATH/Merck
5/07 – 4/08
Efficacy, Safety and Immunogenicity of RotaTeq^TM among Infants in Asia and Africa